Ratings by Oppenheimer (Leland Gershell)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/28/2021 Clene, Inc. CLNN New Coverage Outperform
(N/A)
7.18
(5.73)
-20.19% Details
9/20/2021 Clarus CRXT New Coverage Outperform
(N/A)
8.81
(4.19)
-52.44% Details
8/27/2021 Veru, Inc. VERU Maintain Outperform
(N/A)
 
 
  Details
8/13/2021 CASI Pharmaceuticals CASI Maintain Outperform
(N/A)
 
 
  Details
8/13/2021 Veru, Inc. VERU Maintain Outperform
(N/A)
 
 
  Details
8/12/2021 Milestone Pharmaceuticals MIST Maintain Outperform
(N/A)
 
 
  Details
7/22/2021 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
7/15/2021 PLx Pharma PLXP Maintain Outperform
(N/A)
 
 
  Details
6/9/2021 PDS Biotechnology Corp PDSB Maintain Outperform
(N/A)
 
 
  Details
6/4/2021 Windtree Therapeutics WINT New Coverage Outperform
(N/A)
1.98
(1.88)
-5.05% Details
5/24/2021 Cerecor CERC Maintain Outperform
(N/A)
 
 
  Details
5/6/2021 Baudax Bio Inc. BXRX Maintain Outperform
(N/A)
 
 
  Details
5/5/2021 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
4/9/2021 PLx Pharma PLXP New Coverage Outperform
(N/A)
9.00
(13.47)
49.67% Details
3/31/2021 Milestone Pharmaceuticals MIST Maintain Outperform
(N/A)
 
 
  Details
3/30/2021 Ascendis Pharma ASND Downgrade Perform
(Outperform)
128.86
(144.61)
12.22% Details
3/26/2021 Viridian Therapeutic VRDN Maintain Outperform
(N/A)
 
 
  Details
3/19/2021 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
3/19/2021 PDS Biotechnology Corp PDSB Maintain Outperform
(N/A)
 
 
  Details
3/15/2021 Trevena TRVN New Coverage Perform
(N/A)
2.16
(1.10)
-49.07% Details
2/26/2021 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
2/17/2021 Protera Therapeutics TARA New Coverage Outperform
(N/A)
20.88
(6.71)
-67.86% Details
2/17/2021 Baudax Bio Inc. BXRX Maintain Outperform
(N/A)
 
 
  Details
2/12/2021 Alnylam Pharmaceuticals ALNY Maintain Perform
(N/A)
 
 
  Details
2/11/2021 Veru, Inc. VERU Maintain Outperform
(N/A)
 
 
  Details
12/31/2020 miRagen Therapeutics MGEN Maintain Outperform
(N/A)
 
 
  Details
12/17/2020 Avenue Therapeutics ATXI Maintain Outperform
(N/A)
 
 
  Details
12/16/2020 Veru, Inc. VERU Maintain Outperform
(N/A)
 
 
  Details
11/25/2020 Teva Pharma TEVA New Coverage Perform
(N/A)
9.61
(10.13)
5.41% Details
11/18/2020 Cerecor CERC Maintain Outperform
(N/A)
 
 
  Details
11/16/2020 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
11/10/2020 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 ADMA Biologics ADMA Maintain Outperform
(N/A)
 
 
  Details
10/23/2020 CASI Pharmaceuticals CASI New Coverage Outperform
(N/A)
1.60
(1.09)
-31.88% Details
10/21/2020 Baudax Bio Inc. BXRX Maintain Outperform
(N/A)
 
 
  Details
9/8/2020 Corbus Pharmaceuticals CRBP Downgrade Perform
(Outperform)
9.25
(0.95)
-89.73% Details
9/1/2020 Acasti Pharma ACST Downgrade Perform
(Outperform)
0.71
(1.68)
136.62% Details
8/28/2020 Ascendis Pharma ASND Maintain Outperform
(N/A)
 
 
  Details
8/28/2020 Ascendis Pharma ASND Maintain Outperform
(N/A)
 
 
  Details
8/25/2020 Brickell Biotech Inc. BBI New Coverage Outperform
(N/A)
0.80
(0.52)
-35% Details
8/14/2020 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
8/13/2020 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
8/12/2020 Baudax Bio Inc. BXRX Maintain Outperform
(N/A)
 
 
  Details
8/11/2020 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
8/11/2020 Alnylam Pharmaceuticals ALNY Downgrade Perform
(Outperform)
138.57
(198.61)
43.33% Details
8/10/2020 Evofem Biosciences Inc EVFM Maintain Outperform
(N/A)
 
 
  Details
8/5/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Perform
(N/A)
 
 
  Details
7/29/2020 Milestone Pharmaceuticals MIST Upgrade Outperform
(Perform)
8.01
(5.56)
-30.59% Details
6/25/2020 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
6/23/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
6/18/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Perform
(N/A)
 
 
  Details
6/9/2020 Soleno Therapeutics Inc. SLNO Maintain Outperform
(N/A)
 
 
  Details
6/8/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
5/27/2020 Evofem Biosciences Inc EVFM Maintain Outperform
(Outperform)
 
 
  Details
5/27/2020 Cerecor CERC Maintain Outperform
(N/A)
 
 
  Details
5/20/2020 Ascendis Pharma ASND Maintain Outperform
(N/A)
 
 
  Details
5/12/2020 Recro Pharma REPH Maintain Outperform
(N/A)
 
 
  Details
5/12/2020 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
5/11/2020 Baudax Bio Inc. BXRX Maintain Outperform
(N/A)
 
 
  Details
5/5/2020 Epizyme EPZM Maintain Perform
(N/A)
 
 
  Details
4/20/2020 Ascendis Pharma ASND Maintain Outperform
(N/A)
 
 
  Details
4/17/2020 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
4/6/2020 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
4/6/2020 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
4/1/2020 Epizyme EPZM Downgrade Perform
(Outperform)
15.51
(4.55)
-70.66% Details
3/31/2020 Avenue Therapeutics ATXI Maintain Outperform
(N/A)
 
 
  Details
3/31/2020 Amarin Corporation AMRN Upgrade Perform
(Outperform)
13.58
(5.00)
-63.18% Details
3/25/2020 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
3/24/2020 Milestone Pharmaceuticals MIST Downgrade Perform
(Outperform)
14.00
(8.01)
-42.79% Details
3/20/2020 Ascendis Pharma ASND New Coverage Outperform
(N/A)
98.40
(144.61)
46.96% Details
3/5/2020 Soleno Therapeutics Inc. SLNO Maintain Outperform
(N/A)
 
 
  Details
3/5/2020 Recro Pharma REPH Maintain Outperform
(N/A)
 
 
  Details
3/5/2020 Recro Pharma REPH Maintain Outperform
(N/A)
 
 
  Details
3/2/2020 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
2/28/2020 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
2/27/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
2/26/2020 Amarin Corporation AMRN Maintain Underperform
(N/A)
 
 
  Details
2/21/2020 Baudax Bio Inc. BXRX Maintain Outperform
(N/A)
 
 
  Details
2/18/2020 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
2/13/2020 Veru, Inc. VERU Maintain Outperform
(N/A)
 
 
  Details
2/12/2020 Amarin Corporation AMRN Maintain Underperform
(N/A)
 
 
  Details
2/11/2020 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
2/7/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
2/7/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
1/31/2020 miRagen Therapeutics MGEN Maintain Perform
(N/A)
 
 
  Details
1/29/2020 Outlook Therapeutics Incs. OTLK Maintain Outperform
(N/A)
 
 
  Details
1/28/2020 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
1/22/2020 Amarin Corporation AMRN Maintain Underperform
(N/A)
 
 
  Details
1/21/2020 Baudax Bio Inc. BXRX Maintain Outperform
(N/A)
 
 
  Details
1/13/2020 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
1/10/2020 Cerecor CERC New Coverage Outperform
(N/A)
4.67
(2.93)
-37.26% Details
1/7/2020 Amarin Corporation AMRN Maintain Underperform
(N/A)
 
 
  Details
12/26/2019 Acasti Pharma ACST Maintain Outperform
(N/A)
 
 
  Details
12/23/2019 X4 Pharmaceuticals XFOR New Coverage Outperform
(N/A)
10.40
(4.51)
-56.63% Details
12/23/2019 Soleno Therapeutics Inc. SLNO New Coverage Outperform
(N/A)
1.73
(0.78)
-54.91% Details
12/17/2019 miRagen Therapeutics MGEN Maintain Outperform
(N/A)
 
 
  Details
12/16/2019 Amarin Corporation AMRN Maintain Underperform
(N/A)
 
 
  Details
12/3/2019 Evofem Biosciences Inc EVFM Maintain Outperform
(N/A)
 
 
  Details
12/3/2019 Evofem Biosciences Inc EVFM Maintain Outperform
(N/A)
 
 
  Details
11/26/2019 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
11/20/2019 Amarin Corporation AMRN New Coverage Underperform
(N/A)
22.60
(13.58)
-39.91% Details
11/20/2019 Alnylam Pharmaceuticals ALNY New Coverage Outperform
(N/A)
92.73
(198.61)
114.18% Details
11/18/2019 Anchiano Therapeutics ANCN Downgrade Perform
(Outperform)
1.92
(4.71)
145.31% Details
11/14/2019 Catalyst Pharmaceutical Partners CPRX Maintain Outperform
(N/A)
 
 
  Details
11/13/2019 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
11/11/2019 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
11/8/2019 Recro Pharma REPH Maintain Outperform
(N/A)
 
 
  Details
11/6/2019 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
10/31/2019 Epizyme EPZM Maintain Outperform
(N/A)
 
 
  Details
10/31/2019 Catalyst Pharmaceutical Partners CPRX Maintain Outperform
(N/A)
 
 
  Details
10/31/2019 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
10/31/2019 Epizyme EPZM Maintain Outperform
(N/A)
 
 
  Details
10/31/2019 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
10/31/2019 Catalyst Pharmaceutical Partners CPRX Maintain Outperform
(N/A)
 
 
  Details
10/29/2019 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
10/29/2019 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
10/24/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Perform
(N/A)
 
 
  Details
9/17/2019 Acceleron Pharma XLRN Maintain Outperform
(N/A)
 
 
  Details
8/9/2019 Recro Pharma REPH Maintain Outperform
(N/A)
 
 
  Details
8/2/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Perform
(N/A)
 
 
  Details
7/18/2019 Acasti Pharma ACST New Coverage Outperform
(N/A)
1.40
(1.68)
20% Details
6/25/2019 ADMA Biologics ADMA Maintain Outperform
(N/A)
 
 
  Details
6/19/2019 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
6/14/2019 Veru, Inc. VERU Maintain Outperform
(N/A)
 
 
  Details
6/6/2019 Agile Therapeutics AGRX New Coverage Outperform
(N/A)
1.11
(0.81)
-27.03% Details
6/4/2019 Milestone Pharmaceuticals MIST New Coverage Perform
(N/A)
20.70
(14.00)
-32.37% Details
5/16/2019 Outlook Therapeutics Incs. OTLK New Coverage Outperform
(N/A)
1.03
(2.12)
105.83% Details
4/26/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Perform
(N/A)
 
 
  Details
4/22/2019 Acceleron Pharma XLRN New Coverage Outperform
(N/A)
39.69
(173.95)
338.27% Details
4/12/2019 Evofem Biosciences Inc EVFM Maintain Outperform
(N/A)
 
 
  Details
4/4/2019 Recro Pharma REPH Maintain Outperform
(N/A)
 
 
  Details
4/2/2019 ADMA Biologics ADMA Maintain Outperform
(N/A)
 
 
  Details
3/25/2019 Recro Pharma REPH Maintain Outperform
(Outperform)
 
 
  Details
3/21/2019 miRagen Therapeutics MGEN New Coverage Outperform
(N/A)
3.32
(23.01)
593.07% Details
3/20/2019 Catalyst Pharmaceutical Partners CPRX Maintain Outperform
(N/A)
 
 
  Details
3/19/2019 Veru, Inc. VERU New Coverage Outperform
(N/A)
1.49
(8.09)
442.95% Details
3/19/2019 Corbus Pharmaceuticals CRBP New Coverage Outperform
(N/A)
6.70
(9.25)
38.06% Details
3/11/2019 Anchiano Therapeutics ANCN New Coverage Outperform
(N/A)
7.84
(1.92)
-75.51% Details
2/28/2019 UroGen Pharma URGN Maintain Outperform
(N/A)
 
 
  Details
2/27/2019 Epizyme EPZM New Coverage Outperform
(N/A)
13.76
(4.55)
-66.93% Details
2/27/2019 MEI Pharma MEIP New Coverage Outperform
(N/A)
2.80
(2.81)
0.36% Details
2/26/2019 AzurRx Biopharma AZRX Maintain Outperform
(N/A)
 
 
  Details
2/22/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Perform
(Perform)
 
 
  Details
2/13/2019 ADMA Biologics ADMA Maintain Outperform
(N/A)
 
 
  Details
1/16/2019 VBI Vaccines VBIV New Coverage Outperform
(N/A)
1.80
(3.04)
68.89% Details
12/18/2018 Catalyst Pharmaceutical Partners CPRX Maintain Outperform
(Outperform)
 
 
  Details
12/14/2018 BioMarin Pharmaceutical Inc. BMRN New Coverage Perform
(N/A)
94.51
(73.74)
-21.98% Details
11/15/2018 Avenue Therapeutics ATXI Maintain Outperform
(N/A)
 
 
  Details
10/17/2018 AzurRx Biopharma AZRX New Coverage Outperform
(N/A)
2.50
(3.45)
38% Details
10/10/2018 AcelRx Pharmaceuticals ACRX Maintain Perform
(N/A)
 
 
  Details
9/4/2018 Vaccinex VCNX New Coverage Outperform
(N/A)
9.99
(1.83)
-81.68% Details